Eli Lilly and Co/ US5324571083 /
21/05/2024 22:10:00 | Var. +19.99 | Volume | Denaro02:00:00 | Lettera02:00:00 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
803.17USD | +2.55% | 4.33 mill. Fatturato: 1.86 bill. |
804.00Quantità in denaro: 200 | 807.29Quantità in lettera: 200 | 763.34 bill.USD | 0.58% | 138.00 |
GlobeNewswire
08:35
HKQAA upgrades Guotai Junan International's sustainable development rating to BBB+
GlobeNewswire
07:30
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treat...
GlobeNewswire
07:30
Aalberts N.V.: Aalberts sustained added value margin in challenging market environment
GlobeNewswire
07:25
Trial carbon capture unit begins operating on Blast Furnace at ArcelorMittal Gent, Belgium
GlobeNewswire
07:00
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilar...